SHIELD – Sustainable High Yield | Yield trade to return as currency strengthens

Mathan Somasundaram

Deep Data Analytics

Macro Outlook: Central banks policies continue to remain a deterrent for the global economy to evolve. The return of the currency wars will maintain low growth, falling commodities and low to negative interest rates into the future. Falling bond yields and low growth will drive investors towards high yielding Australian equities. The US Fed is expected to maintain rates while more stimulus expectations are rising in Japan, China and Europe. Growth in US is likely to pull back while Euro recovery will take time. Australian equities have been sold down on the currency trade through the past 12 months. The current risk/return profile suggests we are likely to see this trade reverse as yield premium widens and USD weakens. SHIELD Top 20 picks are: large cap – CBA, WBC, ANZ, TLS and BHP; mid cap – MFG, CGF, HGG, QAN and PPT; small cap – OFX, PTM, MOC, CCV, RCR and AGI; and micro cap – LOV, DDR, SIQ and VTG. (VIEW LINK)


Mathan Somasundaram
Founder & CEO
Deep Data Analytics

Over 30 years’ experience in the finance/tech industry. Mathan has worked extensively in all parts of the finance sector (i.e. County NatWest, Citi, LIM, Southern Cross, Bell Potter, Baillieu Holst and Blue Ocean Equities). Currently Founder and...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment